Literature DB >> 1091348

Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases.

P Littman, C C Wang.   

Abstract

Reticulum cell sarcoma of the brain is a rare neoplasm. However, patients who have been recipients of transplants have had a much higher than expected incidence of this tumor; reticulum cell sarcomas of the brain may be seen more often in the future. Most of the information available in the literature deals with the pathology and clinical course of the disease. Although several authors have commented on the radioresponsiveness of the tumor, little detail as to the exact treatment methods has been provided. Furthermore, it has been assumed that the prognosis of this tumor, after some form of surgery and postoperative radiotherapy, may be fairly good. This paper presents 19 patients who have had surgery followed by postoperative radiotherapy. Although a few patients have had good relief of symptoms for 3 to 4 years, only 1 patient is alive and free of disease over 5 years. This patient is the sixth reported long-term survival in the literature. Suggestions for the management of this disease are provided. If possible, limited surgery to remove circumscribed tumors should be done, but extensive resection should be avoided. Postoperative irradiation should include the whole brain to at least 4500 rads at 1000 rads per week, with a boost to residual tumor, if present, of 500 to 1000 rads in two to five treatments.

Entities:  

Mesh:

Year:  1975        PMID: 1091348     DOI: 10.1002/1097-0142(197505)35:5<1412::aid-cncr2820350526>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

Review 1.  Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).

Authors:  D F Nelson
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

2.  Primary lymphoma of the central nervous system.

Authors:  P Fernandes; A D Chowdhury; K G Badami; N R Dutta; G K Rath
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

3.  Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain.

Authors:  M Watanabe; R Tanaka; N Takeda; K Wakabayashi; H Takahashi
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

4.  Reticulum cell sarcoma with unusual presenting features: fever and low cerebrospinal fluid glucose levels.

Authors:  M J Wong; R M Chan; S N Stordy
Journal:  Can Med Assoc J       Date:  1984-10-15       Impact factor: 8.262

5.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Involvement of the central nervous system in malignant lymphomas.

Authors:  K Jellinger; T Radiaszkiewicz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-07-21

7.  The need for prophylactic treatment to the central nervous system in patients with aggressive non-Hodgkin's lymphoma.

Authors:  C J Hawkey; P J Toghill
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

8.  Prognosis of primary central nervous system lymphoma treated with radiotherapy alone.

Authors:  Senzo Taguchi; Yasushi Hamamoto; Takashi Fujii; Takashi Ochi; Hironobu Harada; Takanori Ohnishi; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2012-09-11       Impact factor: 2.374

9.  Immunoperoxidase study of primary central nervous system lymphomas.

Authors:  K J Fan; G Pezeshkpour
Journal:  J Natl Med Assoc       Date:  1985-09       Impact factor: 1.798

Review 10.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.